Renal cancer in von Hippel–Lindau disease and related syndromes

Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3

(2012) Angelica Malinoc et al.   ENDOCRINE-RELATED CANCER

Survival and Impact of Clinical Prognostic Factors in Surgically Treated Metastatic Renal Cell Carcinoma

(2012) Lorenzo Tosco et al.   EUROPEAN UROLOGY

Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up

(2012) C. A. Jilg et al.   Familial Cancer

Life expectancy in hereditary cancer predisposing diseases: an observational study

(2012) Anna Wilding et al.   JOURNAL OF MEDICAL GENETICS

Succinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer

(2012) Christopher J. Ricketts et al.   JOURNAL OF UROLOGY

Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery

(2011) Sung Yoon Park et al.   ACTA RADIOLOGICA

Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology

(2011) Anthony J. Gill et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

(2011) Chris Coppin et al.   BJU INTERNATIONAL

Metastatic Potential in Renal Cell Carcinomas ≤7cm: Swedish Kidney Cancer Quality Register Data

(2011) Eirikur Guðmundsson et al.   EUROPEAN UROLOGY

Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results

(2011) Yoichi Iwamoto et al.   Familial Cancer

New Insights into the Biology of Renal Cell Carcinoma

(2011) Lianjie Li et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Progress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease

(2011) Dominique Joly et al.   JOURNAL OF UROLOGY

Renal Tumors and Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 4

(2011) Anthony J. Gill et al.   NEW ENGLAND JOURNAL OF MEDICINE

Growth Kinetics in Von Hippel-Lindau-Associated Renal Cell Carcinoma

(2011) C.A. Jilg et al.   UROLOGIA INTERNATIONALIS

VHL-gene Deletion in Single Renal Tubular Epithelial Cells and Renal Tubular Cysts: Further Evidence for a Cyst-dependent Progression Pathway of Clear Cell Renal Carcinoma in von Hippel-Lindau Disease

(2010) Matteo Montani et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Hereditary causes of kidney tumours

(2010) Priscilla Helene Axwijk et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Oncological Outcomes of Partial Nephrectomy for Multifocal Renal Cell Carcinoma Greater Than 4 cm

(2010) Gopal N. Gupta et al.   JOURNAL OF UROLOGY

Percutaneous Radio Frequency Ablation of Renal Tumors in Patients With von Hippel-Lindau Disease: Preliminary Results

(2010) Byung Kwan Park et al.   JOURNAL OF UROLOGY

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

(2010) Jean-Pierre Bayley et al.   LANCET ONCOLOGY

Genotype-phenotype correlations in VHL exon deletions

(2009) Alisdair McNeill et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations inSDHBandSDHD

(2009) Christopher J. Ricketts et al.   HUMAN MUTATION

SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma

(2009) H.-X. Hao et al.   SCIENCE

Patterns of intervention for renal lesions in von Hippel-Lindau disease

(2008) Surena F. Matin et al.   BJU INTERNATIONAL

Germline SDHB Mutations and Familial Renal Cell Carcinoma

(2008) C. Ricketts et al.   JNCI-Journal of the National Cancer Institute

Feasibility and Outcomes of Repeat Partial Nephrectomy

(2008) Aaron Johnson et al.   JOURNAL OF UROLOGY

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

(2008) Robert J Motzer et al.   LANCET